Aljian Capital Management’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

Aljian Capital Management’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-62,532	Closed	-$3.13K	–	40
2023 Q3	$3.13K	Hold	62,532	–	–	﹤0.01%	39
2023 Q2	$13.1K	Hold	62,532	–	–	0.01%	47
2023 Q1	$10K	Hold	62,532	–	–	0.01%	48
2022 Q4	$13.8K	Hold	62,532	–	–	0.01%	49
2022 Q3	$163K	Hold	62,532	–	–	0.09%	49
2022 Q2	$43K	Hold	62,532	–	–	0.02%	55
2022 Q1	$99K	Hold	62,532	–	–	0.04%	57
2021 Q4	$149K	Buy	+62,532	New	+$190K	0.06%	60

Other funds holding CANO.WS

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Aljian Capital Management's CANO.WS Position: Q4 2023 in Review

Aljian Capital Management sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2023, closing a stake of 62,532 shares — an estimated $3.13K sold.

Aljian Capital Management first reported a position in CANO.WS in Q4 2021 and held it in 8 quarters. The position peaked at $163K in Q3 2022. 2 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2023.

Aljian Capital Management reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2023 after selling out during the quarter.
Aljian Capital Management sold 62,532 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2023, an estimated $3.13K.
Aljian Capital Management first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q4 2021 and held it in 8 quarters.
Aljian Capital Management's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $163K in Q3 2022.
2 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2023.

Based on Aljian Capital Management's 13F filing for Q4 2023, filed 18 Jan 2024.